set up 6750 sq ft “Recovery Zone” at Airtel Delhi Half Marathon Finish line- Recovery Zone to have therapists and sports injury counselors
- Pledges to recover runners ‘anytime anywhere’
New Delhi, November 21, 2014: Ranbaxy’s Volini, India’s No. 1 doctor recommended and extensively used pain reliever, has been engaged by Procam International as the official “Recovery Partner” for Airtel Delhi Half Marathon to be held on Sunday, November 23, 2014.
At Airtel Delhi Half Marathon, Volini will be setting-up a Recovery Zone, spread over 6750 sq ft. The Recovery Zone will have masseurs, foam rollers, beds, lounge etc to provide instant relief to the runners and will be supervised by India’s best known sports Scientist Shayamal Vallabhjee. The Recovery Zone will also facilitate instant and long lasting relief from pain and enables marathon runners to recover quickly. Volini has been the most used instant pain relief spray and has proved to be efficient for post marathon recovery and workouts.
Commenting on Volini’s association with Airtel Delhi Half Marathon, Subodh Marwah, Vice President & Head – Consumer Healthcare, Ranbaxy, said, “Volini is delighted to be associated as the Official Recovery Partner of leading marathons of the country, beginning with Airtel Delhi Half Marathon. The association will further strengthen Volini’s position as India’s leading instant pain relieving spray. Running is becoming increasingly popular from a fitness perspective and we are happy to be the preferred choice of the runners when it comes to recovery. Recovery Zones proves our commitment to provide instant relief and recovery from pains in no time.”
Volini by Ranbaxy is a modern day pain reliever scientifically formulated for effective pain relief. It is available in two forms – gel & spray. It can be used for joint, back, neck & shoulder pains, sprains and strains. Committed towards providing instant and long lasting relief, the brand enables people to maximize life, performance and success wherever they are and whenever they need it.
Over the years, India’s most respected brands have partnered Procam International’s running events for the transformational role they play in bringing individuals, organizations and institutions together towards the healthy lifestyle. In line with Procam International’s efforts to bring some of the world’s most accomplished sports people to India to raise the profile of distance running as a sport, Paula Radcliffe, English long-distance runner and the current women’s world record holder in the marathon will be the ‘Official Event Ambassador’ of Airtel Delhi Half Marathon 2014.
About Volini
Ranbaxy’s Volini is a modern day pain reliever scientifically formulated for effective pain relief. It is the No. 1 doctor recommended and used pain reliever that is available in two formats – Gel & Spray. It can be used for Joint, Back, Neck & Shoulder pains, sprains & strains. Since its switch from Rx to OTC, the brand has grown leaps and bounds, and today is one of India’s biggest pain relieving brands. Committed towards providing instant and long lasting relief, the brand enables people to maximize life, performance and success wherever they are and whenever they need it.
About Ranbaxy
Ranbaxy Laboratories Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 150 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 43 countries and manufacturing operations in 8 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visitwww.ranbaxy.com.